Navigation Links
Raising Awareness of Rare Diseases, Anson Group Announces Sponsorship of Rare Disease Day
Date:2/27/2010

Anson Group, a sponsor for Rare Disease Day, hopes to bring more attention to the need for finding more treatments for diseases which affect a smaller patient population.

Indianapolis, IN (Vocus) February 27, 2010 -- The Anson Group hopes to draw more attention to the urgent need of finding more treatments for rare diseases by partnering with the National Organization for Rare Diseases (NORD) to sponsor Rare Disease Day in the United States, February 28th, 2010.

Anson Group, a regulatory consulting company, has had the privilege of providing regulatory support for multiple products that are indicated for the treatment of a number of rare diseases. Anson has aided clients in obtaining Orphan Drug status (for pharmaceutical entities) and Humanitarian Use Designations (for medical devices) for products intended to treat diseases like gastrointestinal stromal tumor (GIST), mastocytosis and multiple myeloma, as well as multiple sclerosis and amyotrophic lateral sclerosis (ALS). Most recently, Anson Group helped prepare materials for an FDA Advisory Committee meeting regarding a new treatment for Niemann-Pick Type C (NPC) disease.

Anson supports the need for continued research and innovation in rare diseases. As scientists continue to work to evolve treatments to target more specific disease pathways, subpopulations and rare diseases will become increasingly important in the understanding and practice of true personalized medicine. Anson Group will continue to invest in building our expertise in regulatory requirements for these products in order to expand our role in ensuring promising treatments reach the market for those who suffer from rare conditions.

“Anson is proud of our 15 year history of helping all of our clients get their medical technologies to market as quickly as possible and in compliance with the applicable regulations; that said, no project
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related biology technology :

1. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
2. Volatile Economy / Fundraising Challenges Encourage Business Combinations Among Biotech Companies According to New Survey from CPA Firm Rothstein Kass
3. Novagali Pharma Completes a EUR15 Million Fund Raising
4. Arbel Medical has Completed a $4.5 million Round of Capital Raising led by Giza Venture Capital Fund
5. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
6. Spectrum Announces Support Partnership for Breast Cancer Research During Breast Cancer Awareness Month
7. Accera, Inc. to Support the Alzheimers Foundation of Americas National Memory Screening Day Through On-line Awareness Effort
8. TSH Testing Raises Awareness of Importance of Thyroid Health
9. First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009
10. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
11. Remuda Ranch Programs for Eating and Anxiety Disorders Reports Need for Increasing Awareness of Eating Disorders in Males
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Raising Awareness of Rare Diseases, Anson Group Announces Sponsorship of Rare Disease Day
(Date:5/24/2013)... SAN DIEGO , May 24, 2013 ... a  company using proprietary taste science technologies to discover, ... David Linemeyer , Ph.D., the Company,s ... , Vice President, Investor Relations & Corporate Communications, will ... Friday, May 31, at 10:25 a.m. Eastern Time (7:25 ...
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") ... science-based research and development, sales and marketing of ... announced today that it is awarding exclusive Vestiage ... of Reluma Skin Illuminating Facial Care. Qualified applicants ... sending an email to info(at)vestiageinc(dot)com and putting RELUMA ...
(Date:5/23/2013)... , May 23, 2013 Venaxis, Inc. ... company focused on obtaining FDA clearance and commercializing its ... announced the pricing of an underwritten public offering of ... to purchase 3,500,000 shares of its common stock at ... combined public offering price of $1.25 per share and ...
(Date:5/23/2013)... May 23, 2013 Patheon Inc ... services to the global pharmaceutical industry, will host a ... Approaches to Testing” on Tuesday, June 4, 2013 at ... manufacturers are required to comply with regulations for cleaning ... with limited scientific underpinning and little evaluation of risk. ...
Breaking Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2
... An engineered metamaterial proved it can function as ... the electromagnetic spectrum, setting a standard of performance for ... of researchers from Boston College, the Los Alamos ... electrical current applied to the metamaterial a hybrid ...
... of MyMedicalRecords Pro to be Showcased For ... at HIMSS09LOS ANGELES, Feb. 24 MMR ... which through its wholly-owned operating subsidiary, MyMedicalRecords, ... Records ("PHRs") ( www.mymedicalrecords.com ) and electronic ...
... The European Commission has granted,marketing authorisation for ... the treatment of adult patients,with major depressive episodes. ... great scope for improved therapies to treat the,devastating ... Oxford, United Kingdom. "Valdoxan is an innovative, new ...
Cached Biology Technology:Team develops new metamaterial device 2Team develops new metamaterial device 3MMR Seeks Its Slice of the Billion-Dollar Stimulus Pie 2MMR Seeks Its Slice of the Billion-Dollar Stimulus Pie 3MMR Seeks Its Slice of the Billion-Dollar Stimulus Pie 4MMR Seeks Its Slice of the Billion-Dollar Stimulus Pie 5Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe 2Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe 3
(Date:5/23/2013)... discovering the new mechanism by which estrogen suppresses lipid ... a potential new approach toward treating certain liver diseases. ... colleagues believe they are changing long-held views in the ... of the journal Science Signaling . , "The ... has been that only receptors located in the nucleus ...
(Date:5/23/2013)... surgery or harsh treatments because science fails to ... of the disease. Researchers at Case Western Reserve ... technology that allows patients to safely choose to ... take drastic measures. , The project is one ... biomedical engineering at Case Western Reserve and director ...
(Date:5/23/2013)... history museums of the world are billions of animal ... flowers, mushrooms and grasses, all stacked, stored and preserved ... diverse collections could be critical to understanding how the ... growing human footprint if only the information were ... life with the help of a team from the ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4
... Weizmann Institute scientists has turned the tables on an autoimmune ... immune system mistakenly attacks the body,s tissues. But the scientists ... one of the body,s players in autoimmune processes, an enzyme ... in Nature Medicine . Prof. Irit Sagi of ...
... Friday, December 23, 2011, Cleveland: Cleveland Clinic researchers ... thyroid cancer, which is has the largest incidence increase ... led by Charis Eng, M.D., Ph.D., Chair and founding ... Lerner Research Institute, included nearly 3,000 patients with Cowden ...
... Many imaging technologies and their contrast agents chemicals used ... involve exposure to radiation or heavy metals, which present potential ... be applied. In an effort to mitigate these drawbacks, new ... coat an iron-based contrast agent so that it only interacts ...
Cached Biology News:New synthetic molecules treat autoimmune disease in mice 2Cleveland Clinic researcher discovers genetic cause of thyroid cancer 2Penn engineers develop more effective MRI contrast agent for cancer detection 2Penn engineers develop more effective MRI contrast agent for cancer detection 3
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
... to just 15 minutes! The name Instant ... be drawn between this exciting new laboratory concept ... Instant meals consumed by astronauts, explorers and ... reconstituted by adding water. The Instant ELISA ...
Request Info...
Request Info...
Biology Products: